127 related articles for article (PubMed ID: 10672928)
1. TCR internalization induced by peptide/MHC ligands requires the transmembrane domains of alphabeta chains of TCR, but not the expression of CD8 and Thy-1 molecules.
Lee MH; Min D; Sonn CH; Lee KN; Kim KE; Paik SG; Kim YS
Mol Cells; 1999 Dec; 9(6):617-24. PubMed ID: 10672928
[TBL] [Abstract][Full Text] [Related]
2. Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions.
Shen L; Potter TA; Kane KP
J Exp Med; 1996 Nov; 184(5):1671-83. PubMed ID: 8920857
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous clustering of Thy-1 antigens on CD4+ CD8+ thymocytes lacking TCR engagement by MHC/peptide complexes.
Sano T; Yamamoto K; Fukui Y; Sasazuki T
Eur J Immunol; 1999 Feb; 29(2):403-12. PubMed ID: 10064055
[TBL] [Abstract][Full Text] [Related]
4. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
Lustgarten J; Waks T; Eshhar Z
Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
[TBL] [Abstract][Full Text] [Related]
5. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
6. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties.
Laugel B; van den Berg HA; Gostick E; Cole DK; Wooldridge L; Boulter J; Milicic A; Price DA; Sewell AK
J Biol Chem; 2007 Aug; 282(33):23799-810. PubMed ID: 17540778
[TBL] [Abstract][Full Text] [Related]
7. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
[TBL] [Abstract][Full Text] [Related]
8. Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes.
de Vries JE; Yssel H; Spits H
Immunol Rev; 1989 Jun; 109():119-41. PubMed ID: 2527803
[TBL] [Abstract][Full Text] [Related]
9. CD8alpha/alpha homodimers fail to function as co-receptor for a CD8-dependent TCR.
McNicol AM; Bendle G; Holler A; Matjeka T; Dalton E; Rettig L; Zamoyska R; Uckert W; Xue SA; Stauss HJ
Eur J Immunol; 2007 Jun; 37(6):1634-41. PubMed ID: 17506031
[TBL] [Abstract][Full Text] [Related]
10. Homology between an alloantigen and a self MHC allele calibrates the avidity of the alloreactive T cell repertoire independent of TCR affinity.
Hornell TM; Myers N; Hansen TH; Connolly JM
J Immunol; 2003 May; 170(9):4506-14. PubMed ID: 12707327
[TBL] [Abstract][Full Text] [Related]
11. Rescue of cytotoxic function in the CD8alpha knockout mouse by removal of MHC class II.
Riddle DS; Miller PJ; Vincent BG; Kepler TB; Maile R; Frelinger JA; Collins EJ
Eur J Immunol; 2008 Jun; 38(6):1511-21. PubMed ID: 18465769
[TBL] [Abstract][Full Text] [Related]
12. Resting and activated T cells display different requirements for CD8 molecules.
Cai Z; Sprent J
J Exp Med; 1994 Jun; 179(6):2005-15. PubMed ID: 8195722
[TBL] [Abstract][Full Text] [Related]
13. Growth-dependent variation of major histocompatibility complex (MHC) restriction and expression of Ly-2 and CD3/alpha/beta T cell receptor in cloned cytotoxic T cells.
Weltzien HU; Kempkes B; Studer R; Melchers I; Eichmann K
Eur J Immunol; 1988 Mar; 18(3):431-7. PubMed ID: 2965649
[TBL] [Abstract][Full Text] [Related]
14. The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain.
Purbhoo MA; Boulter JM; Price DA; Vuidepot AL; Hourigan CS; Dunbar PR; Olson K; Dawson SJ; Phillips RE; Jakobsen BK; Bell JI; Sewell AK
J Biol Chem; 2001 Aug; 276(35):32786-92. PubMed ID: 11438524
[TBL] [Abstract][Full Text] [Related]
15. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and functional association between CD8 and H-2 at the surface of a T cell clone.
Auphan N; Boyer C; Andre P; Bongrand P; Schmitt-Verhulst AM
Mol Immunol; 1991 Aug; 28(8):827-37. PubMed ID: 1678858
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic and syngeneic class I MHC complexes drive the association of CD8 and TCR on 2C T cells.
Lee PU; Kranz DM
Mol Immunol; 2003 Jan; 39(12):687-95. PubMed ID: 12531280
[TBL] [Abstract][Full Text] [Related]
18. H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity.
Casanova JL; Cerottini JC; Matthes M; Necker A; Gournier H; Barra C; Widmann C; MacDonald HR; Lemonnier F; Malissen B; Maryanski JL
J Exp Med; 1992 Aug; 176(2):439-47. PubMed ID: 1380061
[TBL] [Abstract][Full Text] [Related]
19. Role of CD8 in aberrant function of cytotoxic T lymphocytes.
Kessler B; Hudrisier D; Cerottini JC; Luescher IF
J Exp Med; 1997 Dec; 186(12):2033-8. PubMed ID: 9396772
[TBL] [Abstract][Full Text] [Related]
20. Probing the activation requirements for naive CD8+ T cells with Drosophila cell transfectants as antigen presenting cells.
Cai Z; Brunmark AB; Luxembourg AT; Garcia KC; Degano M; Teyton L; Wilson I; Peterson PA; Sprent J; Jackson MR
Immunol Rev; 1998 Oct; 165():249-65. PubMed ID: 9850865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
